Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | FNTA | P49354 | 1/20 | 0.40 |
| ▸ | FNTB | P49356 | 1/20 | 0.40 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.38 |
| ▸ | FDPS | P14324 | 2/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9578903 | 1.00 | ALOX15 (0.50) | ALOX15ALDH1A1USP2TSHRFNTA | |
| SCHEMBL9578905 | 1.00 | ALOX15 (0.50) | ALOX15ALDH1A1USP2TSHRFNTA | |
| SCHEMBL7933530 | 1.00 | ALOX15 (0.50) | ALOX15ALDH1A1USP2TSHRFNTA | |
| SCHEMBL1150421 | 0.87 | ALOX15 (0.49) | ALOX15ALDH1A1USP2TSHRFNTA | |
| SCHEMBL523093 | 0.87 | ALOX15 (0.49) | ALOX15ALDH1A1USP2TSHRFNTA | |
| SCHEMBL523092 | 0.87 | ALOX15 (0.49) | ALOX15ALDH1A1USP2TSHRFNTA | |
| SCHEMBL1150423 | 0.87 | ALOX15 (0.49) | ALOX15ALDH1A1USP2TSHRFNTA | |
| SCHEMBL11861700 | 0.87 | ALOX15 (0.57) | ALOX15ALDH1A1USP2TSHRFNTA | |
| SCHEMBL11861697 | 0.87 | ALOX15 (0.57) | ALOX15ALDH1A1USP2TSHRFNTA | |
| SCHEMBL11850606 | 0.86 | ALOX15 (0.45) | ALOX15ALDH1A1USP2TSHRFNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2935176-B1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-3,7-DIMETYLOCT-6-ENAL | DSM IP ASSETS BV (NL) | 2018-08-01 | — | — | EP | claimed |
| EP-2935176-A1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-3,7-DIMETYLOCT-6-ENAL | DSM IP Assets B.V. (NL) | 2015-10-28 | — | — | EP | claimed |
| WO-2014096066-A1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-3,7-DIMETYLOCT-6-ENAL | DSM IP ASSETS B.V. (NL) | 2014-06-26 | — | — | WO | claimed |
| US-4032588-A | REACTING KETONE WITH ACETYLENE, HYDROCRACKING | SHISEIDO CO., LTD. (JA) | 1977-06-28 | — | — | US | claimed |
| EP-2935176-B1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-3,7-DIMETYLOCT-6-ENAL | DSM IP ASSETS BV (NL) | 2018-08-01 | — | — | EP | disclosed |
| EP-2935176-A1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-3,7-DIMETYLOCT-6-ENAL | DSM IP Assets B.V. (NL) | 2015-10-28 | — | — | EP | disclosed |
| WO-2014096066-A1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-3,7-DIMETYLOCT-6-ENAL | DSM IP ASSETS B.V. (NL) | 2014-06-26 | — | — | WO | disclosed |
| US-6303823-B2 | ?CROSSED ALDOL CONDENSATION? OF A KETONE WITH AN ALDEHYDE IN THE PRESENCE OF A CATALYST SYSTEM CONSISTING OF DIMETHYLAMINE OR PYRROLIDINE AND A CARBOXYLIC ACID TO FORM AN ALPHA,BETA-UNSATURATED KETONE | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-16 | — | — | US | disclosed |
| US-20010003784-A1 | Process for preparing ketones, in particular 6-methylheptan-2-one | BASF AKTIENGESELLSCAFT (DE) | 2001-06-14 | — | — | US | disclosed |
| EP-1106597-A1 | Process for the preparation of ketones, especially 6-methyl-heptan-2-one | BASF AKTIENGESELLSCHAFT (DE) | 2001-06-13 | — | — | EP | disclosed |
| US-4032588-A | REACTING KETONE WITH ACETYLENE, HYDROCRACKING | SHISEIDO CO., LTD. (JA) | 1977-06-28 | — | — | US | disclosed |
| US-4032588-A | REACTING KETONE WITH ACETYLENE, HYDROCRACKING | SHISEIDO CO., LTD. (JA) | 1977-06-28 | — | — | US | disclosed |
| US-3970704-A | Alkoxy substituted aliphatic di-olefinic halides | ZOECON CORPORATION (US) | 1976-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010003784-A1 | Process for preparing ketones, in particular 6-methylheptan-2-one | ADH1A, ADH1C, ADH5 | ALOX15 237/4885ALDH1A1 54/4885USP2 1259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.